119 related articles for article (PubMed ID: 38776197)
1. RedCDR: Dual Relation Distillation for Cancer Drug Response Prediction.
Xu M; Zhu Z; Zhao Y; He K; Huang Q; Zhao Y
IEEE/ACM Trans Comput Biol Bioinform; 2024 May; PP():. PubMed ID: 38776197
[TBL] [Abstract][Full Text] [Related]
2. Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.
Park S; Soh J; Lee H
BMC Bioinformatics; 2021 May; 22(1):269. PubMed ID: 34034645
[TBL] [Abstract][Full Text] [Related]
3. The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer.
Wang C; Zhang M; Zhao J; Li B; Xiao X; Zhang Y
Comput Biol Med; 2023 Sep; 163():107220. PubMed ID: 37406589
[TBL] [Abstract][Full Text] [Related]
4. MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning.
Li Y; Guo Z; Gao X; Wang G
Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38070154
[TBL] [Abstract][Full Text] [Related]
5. DeepFusionCDR: Employing Multi-Omics Integration and Molecule-Specific Transformers for Enhanced Prediction of Cancer Drug Responses.
Hu X; Zhang P; Zhang J; Deng L
IEEE J Biomed Health Inform; 2024 Jun; PP():. PubMed ID: 38935469
[TBL] [Abstract][Full Text] [Related]
6. Integration of incomplete multi-omics data using Knowledge Distillation and Supervised Variational Autoencoders for disease progression prediction.
Ranjbari S; Arslanturk S
J Biomed Inform; 2023 Nov; 147():104512. PubMed ID: 37813325
[TBL] [Abstract][Full Text] [Related]
7. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
[TBL] [Abstract][Full Text] [Related]
8. Prediction of drug sensitivity based on multi-omics data using deep learning and similarity network fusion approaches.
Liu XY; Mei XY
Front Bioeng Biotechnol; 2023; 11():1156372. PubMed ID: 37139048
[TBL] [Abstract][Full Text] [Related]
9. Deep learning and multi-omics approach to predict drug responses in cancer.
Wang C; Lye X; Kaalia R; Kumar P; Rajapakse JC
BMC Bioinformatics; 2022 Nov; 22(Suppl 10):632. PubMed ID: 36443676
[TBL] [Abstract][Full Text] [Related]
10. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
11. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
Peng W; Liu H; Dai W; Yu N; Wang J
Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
[TBL] [Abstract][Full Text] [Related]
12. MOGAT: A Multi-Omics Integration Framework Using Graph Attention Networks for Cancer Subtype Prediction.
Tanvir RB; Islam MM; Sobhan M; Luo D; Mondal AM
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474033
[TBL] [Abstract][Full Text] [Related]
13. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Huang S; Hu P; Lakowski TM
BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
[TBL] [Abstract][Full Text] [Related]
14. GraphCDR: a graph neural network method with contrastive learning for cancer drug response prediction.
Liu X; Song C; Huang F; Fu H; Xiao W; Zhang W
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34727569
[TBL] [Abstract][Full Text] [Related]
15. Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.
Liu X; Song C; Liu S; Li M; Zhou X; Zhang W
Bioinformatics; 2022 Oct; 38(20):4782-4789. PubMed ID: 36000898
[TBL] [Abstract][Full Text] [Related]
16. DSPLMF: A Method for Cancer Drug Sensitivity Prediction Using a Novel Regularization Approach in Logistic Matrix Factorization.
Emdadi A; Eslahchi C
Front Genet; 2020; 11():75. PubMed ID: 32174963
[TBL] [Abstract][Full Text] [Related]
17. DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery.
Lan W; Liao H; Chen Q; Zhu L; Pan Y; Chen YP
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38678587
[TBL] [Abstract][Full Text] [Related]
18. MUMA: a multi-omics meta-learning algorithm for data interpretation and classification.
Huang HH; Shu J; Liang Y
IEEE J Biomed Health Inform; 2024 Feb; PP():. PubMed ID: 38345953
[TBL] [Abstract][Full Text] [Related]
19. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
20. FGCNSurv: dually fused graph convolutional network for multi-omics survival prediction.
Wen G; Li L
Bioinformatics; 2023 Aug; 39(8):. PubMed ID: 37522887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
